CareLit · DOI-Nachweis · Klinische Neurophysiologie
Experience with a new botulinum toxin type A (BTA) formulation in the treatment of sialorrhea
DOI 10.1055/s-2007-1032244
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Wissel, N Kuhle
ZeitschriftKlinische Neurophysiologie
Ausgabe01/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Purpose: We report our initial experience with a new BTA formulation free of complex proteins in the treatment of sialorrhea. Our aim was to collect data on the safety and efficacy profile of Xeomin injections in saliva glands in a mixed population in neurorehabilitation. Methods: Six patients with neurogenic dysphagia and clinical significant sialorrhea (idiopathic Parkinson's disease=2, multiple system atrophy=1 a…
Zitieren
Zitierempfehlung
J Wissel, N Kuhle (2008) Experience with a new botulinum toxin type A (BTA) formulation in the treatment of sialorrhea. Klinische Neurophysiologie (01). https://doi.org/10.1055/s-2007-1032244
Mit CareLit weiterarbeiten